拱东医疗 (605369.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

19.9x

Market Cap

CNY 3.73B

MomentumView details →

1D Return

−1.74%

YTD Return

−9.38%

RSI (14)

51.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

19.9x

Market Cap

CNY 3.73B

RSI (14)

51.0

MomentumView details →

1D Return

−1.74%

YTD Return

−9.38%

ProfitabilityView details →

Gross Margin

27.98%

Net Margin

4.84%

EBITDA Margin

14.50%

ROE (TTM)

3.27%

ROA (TTM)

2.57%

Asset Turnover

0.54x

GrowthView details →

Revenue YoY

+4.70%

EPS YoY

−62.09%

FCF YoY

+189.62%

Revenue CAGR 3Y

−8.21%

EPS CAGR 3Y

−57.08%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.10

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.13x

Current Ratio

2.73x

Quick Ratio

2.45x

Div Yield

0.89%

Div Rate

CNY 0.15

Div Growth 1Y

−47.50%

Financials snapshotView financials →

Revenue (TTM)

1.16B

Net Income (TTM)

56.09M

Op. CF (TTM)

284.75M

Latest newsMore news →

Gongdong Medical announced that Taizhou Jinchi Investment Management Partnership plans to reduce its stake in the company by up to 1% through centralized bidding trading between September 23, 2026 and December 22, 2026.3d ago

Similar companies

Pulse Biosciences, Inc.PLSE 奥泰生物688606.SH ICU Medical, Inc.ICUI 维力医疗603309.SH 济民健康603222.SH 康德莱603987.SH Find similar companies →

Latest newsMore news →

Gongdong Medical announced that Taizhou Jinchi Investment Management Partnership plans to reduce its stake in the company by up to 1% through centralized bidding trading between September 23, 2026 and December 22, 2026.3d ago